| Financial Year |
March 31 2023 |
| Monetary Funds |
391,228,490.98 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
69,489,462.34 |
| Advances to Suppliers |
27,157,200.25 |
| Other Receivables |
12,058,719.88 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
210,321,501.35 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
6,462,212.60 |
| Other Current Assets |
4,379,960.69 |
| Total Current Assets |
721,097,548.09 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
235,468,519.17 |
| Long-term Equity Investment |
106,524,871.07 |
| Investment Properties |
2,182,648,990.64 |
| Fixed Assetes |
225,793,360.79 |
| Under-construction Projects |
6,423,997.04 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
30,167,312.50 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
18,322,051.01 |
| Deferred Income Tax Assets |
3,356,692.09 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
3,020,778,520.45 |
| Total Assets |
3,741,876,068.54 |
| Short-Term Loans |
163,519,894.75 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
104,455,692.49 |
| Accounts Received In Advance |
16,642,852.17 |
| Employee Compensation Payable |
7,160,182.97 |
| Taxes Payable |
27,137,930.27 |
| Interest Payable |
-- |
| Dividend Payable |
1,866,832.05 |
| Other payables |
625,005,215.97 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,336,163.28 |
| Other Current Liabilities |
17,488,351.50 |
| Sub-Total of Current Liabilities |
1,117,035,107.42 |
| Long-term Loans |
665,640,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
2,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
200,000.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
684,765,020.35 |
| Total Liabilities |
1,801,800,127.77 |
| Paid-In Capital(Or Share Stock) |
761,335,236.00 |
| Capital Surplus |
246,850,085.85 |
| Surplus Reserve |
305,864,261.76 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
620,455,410.17 |
| Minority Stockholder's Interest |
5,570,946.99 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,934,504,993.78 |
| Owner's Equity（Stockholder's Equity） |
1,940,075,940.77 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,741,876,068.54 |
